Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenwei Peng

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
JAMA Surgery|April 3, 2024
Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus: A Randomized Clinical TrialZhenwei Peng, Wenzhe Fan, Zelong Liu, et al.
Molecular Therapy Oncolytics|September 12, 2022
Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradationXuecen Wang, Zhirui Cao, Xin Yue, et al.
Annals of Surgical Oncology|March 22, 2021
Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling ProtocolLili Chen, Shuling Chen, Qian Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation RegulationShuang Li, Xiao Zhao, Tongtong Song, et al.
European Radiology|January 29, 2019
Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRIShi-Ting Feng, Yingmei Jia, Bing Liao, et al.
Acta Pharmaceutica Sinica. B|September 1, 2023
Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapyXin Yue, Tingyu Liu, Xuecen Wang, et al.
Hepatology (Baltimore, Md.)|February 20, 2024
ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancerZhenwei Peng, Guangyan Wei, Pinzhu Huang, et al.
Nature Communications|July 12, 2025
Androgen receptor promotes arachidonic acid metabolism and angiogenic microenvironment in AFP-negative hepatocellular carcinomaZhilong Lin, Xiaofei Liu, Houwei Wang, et al.
Cancer Immunology Research|April 27, 2022
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular CarcinomaSui Peng, Shuling Chen, Wei Hu, et al.
Immunity|May 30, 2024
Intestinal CXCR6<sup>+</sup> ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expressionZhou Liang, Ziwen Tang, Changjian Zhu, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
JAMA Surgery|April 3, 2024
Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus: A Randomized Clinical TrialZhenwei Peng, Wenzhe Fan, Zelong Liu, et al.
Molecular Therapy Oncolytics|September 12, 2022
Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradationXuecen Wang, Zhirui Cao, Xin Yue, et al.
Annals of Surgical Oncology|March 22, 2021
Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling ProtocolLili Chen, Shuling Chen, Qian Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation RegulationShuang Li, Xiao Zhao, Tongtong Song, et al.
European Radiology|January 29, 2019
Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRIShi-Ting Feng, Yingmei Jia, Bing Liao, et al.
Acta Pharmaceutica Sinica. B|September 1, 2023
Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapyXin Yue, Tingyu Liu, Xuecen Wang, et al.
Hepatology (Baltimore, Md.)|February 20, 2024
ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancerZhenwei Peng, Guangyan Wei, Pinzhu Huang, et al.
Nature Communications|July 12, 2025
Androgen receptor promotes arachidonic acid metabolism and angiogenic microenvironment in AFP-negative hepatocellular carcinomaZhilong Lin, Xiaofei Liu, Houwei Wang, et al.
Cancer Immunology Research|April 27, 2022
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular CarcinomaSui Peng, Shuling Chen, Wei Hu, et al.
Immunity|May 30, 2024
Intestinal CXCR6<sup>+</sup> ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expressionZhou Liang, Ziwen Tang, Changjian Zhu, et al.
Pageof 11